Current File : /var/www/html/digiprint/public/site/cyykrh/cache/00a0c19127a436171c974820285491cf
a:5:{s:8:"template";s:9437:"<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<title>{{ keyword }}</title>
<link href="//fonts.googleapis.com/css?family=Open+Sans%3A300%2C400%2C600%2C700%2C800%7CRoboto%3A100%2C300%2C400%2C500%2C600%2C700%2C900%7CRaleway%3A600%7Citalic&subset=latin%2Clatin-ext" id="quality-fonts-css" media="all" rel="stylesheet" type="text/css"/>
<style rel="stylesheet" type="text/css"> html{font-family:sans-serif;-webkit-text-size-adjust:100%;-ms-text-size-adjust:100%}body{margin:0}footer,nav{display:block}a{background:0 0}a:active,a:hover{outline:0}@media print{*{color:#000!important;text-shadow:none!important;background:0 0!important;box-shadow:none!important}a,a:visited{text-decoration:underline}a[href]:after{content:" (" attr(href) ")"}a[href^="#"]:after{content:""}p{orphans:3;widows:3}.navbar{display:none}}*{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}:after,:before{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}html{font-size:62.5%;-webkit-tap-highlight-color:transparent}body{font-family:"Helvetica Neue",Helvetica,Arial,sans-serif;font-size:14px;line-height:1.42857143;color:#333;background-color:#fff}a{color:#428bca;text-decoration:none}a:focus,a:hover{color:#2a6496;text-decoration:underline}a:focus{outline:thin dotted;outline:5px auto -webkit-focus-ring-color;outline-offset:-2px}p{margin:0 0 10px}ul{margin-top:0;margin-bottom:10px}.container{padding-right:15px;padding-left:15px;margin-right:auto;margin-left:auto}@media (min-width:768px){.container{width:750px}}@media (min-width:992px){.container{width:970px}}@media (min-width:1200px){.container{width:1170px}}.container-fluid{padding-right:15px;padding-left:15px;margin-right:auto;margin-left:auto}.row{margin-right:-15px;margin-left:-15px}.col-md-12{position:relative;min-height:1px;padding-right:15px;padding-left:15px}@media (min-width:992px){.col-md-12{float:left}.col-md-12{width:100%}}.collapse{display:none} .nav{padding-left:0;margin-bottom:0;list-style:none}.nav>li{position:relative;display:block}.nav>li>a{position:relative;display:block;padding:10px 15px}.nav>li>a:focus,.nav>li>a:hover{text-decoration:none;background-color:#eee}.navbar{position:relative;min-height:50px;margin-bottom:20px;border:1px solid transparent}@media (min-width:768px){.navbar{border-radius:4px}}@media (min-width:768px){.navbar-header{float:left}}.navbar-collapse{max-height:340px;padding-right:15px;padding-left:15px;overflow-x:visible;-webkit-overflow-scrolling:touch;border-top:1px solid transparent;box-shadow:inset 0 1px 0 rgba(255,255,255,.1)}@media (min-width:768px){.navbar-collapse{width:auto;border-top:0;box-shadow:none}.navbar-collapse.collapse{display:block!important;height:auto!important;padding-bottom:0;overflow:visible!important}}.container-fluid>.navbar-collapse,.container-fluid>.navbar-header{margin-right:-15px;margin-left:-15px}@media (min-width:768px){.container-fluid>.navbar-collapse,.container-fluid>.navbar-header{margin-right:0;margin-left:0}}.navbar-brand{float:left;height:50px;padding:15px 15px;font-size:18px;line-height:20px}.navbar-brand:focus,.navbar-brand:hover{text-decoration:none}@media (min-width:768px){.navbar>.container-fluid .navbar-brand{margin-left:-15px}}.navbar-nav{margin:7.5px -15px}.navbar-nav>li>a{padding-top:10px;padding-bottom:10px;line-height:20px}@media (min-width:768px){.navbar-nav{float:left;margin:0}.navbar-nav>li{float:left}.navbar-nav>li>a{padding-top:15px;padding-bottom:15px}.navbar-nav.navbar-right:last-child{margin-right:-15px}}@media (min-width:768px){.navbar-right{float:right!important}}.clearfix:after,.clearfix:before,.container-fluid:after,.container-fluid:before,.container:after,.container:before,.nav:after,.nav:before,.navbar-collapse:after,.navbar-collapse:before,.navbar-header:after,.navbar-header:before,.navbar:after,.navbar:before,.row:after,.row:before{display:table;content:" "}.clearfix:after,.container-fluid:after,.container:after,.nav:after,.navbar-collapse:after,.navbar-header:after,.navbar:after,.row:after{clear:both}@-ms-viewport{width:device-width}html{font-size:14px;overflow-y:scroll;overflow-x:hidden;-ms-overflow-style:scrollbar}@media(min-width:60em){html{font-size:16px}}body{background:#fff;color:#6a6a6a;font-family:"Open Sans",Helvetica,Arial,sans-serif;font-size:1rem;line-height:1.5;font-weight:400;padding:0;background-attachment:fixed;text-rendering:optimizeLegibility;overflow-x:hidden;transition:.5s ease all}p{line-height:1.7;margin:0 0 25px}p:last-child{margin:0}a{transition:all .3s ease 0s}a:focus,a:hover{color:#121212;outline:0;text-decoration:none}.padding-0{padding-left:0;padding-right:0}ul{font-weight:400;margin:0 0 25px 0;padding-left:18px}ul{list-style:disc}ul>li{margin:0;padding:.5rem 0;border:none}ul li:last-child{padding-bottom:0}.site-footer{background-color:#1a1a1a;margin:0;padding:0;width:100%;font-size:.938rem}.site-info{border-top:1px solid rgba(255,255,255,.1);padding:30px 0;text-align:center}.site-info p{color:#adadad;margin:0;padding:0}.navbar-custom .navbar-brand{padding:25px 10px 16px 0}.navbar-custom .navbar-nav>li>a:focus,.navbar-custom .navbar-nav>li>a:hover{color:#f8504b}a{color:#f8504b}.navbar-custom{background-color:transparent;border:0;border-radius:0;z-index:1000;font-size:1rem;transition:background,padding .4s ease-in-out 0s;margin:0;min-height:100px}.navbar a{transition:color 125ms ease-in-out 0s}.navbar-custom .navbar-brand{letter-spacing:1px;font-weight:600;font-size:2rem;line-height:1.5;color:#121213;margin-left:0!important;height:auto;padding:26px 30px 26px 15px}@media (min-width:768px){.navbar-custom .navbar-brand{padding:26px 10px 26px 0}}.navbar-custom .navbar-nav li{margin:0 10px;padding:0}.navbar-custom .navbar-nav li>a{position:relative;color:#121213;font-weight:600;font-size:1rem;line-height:1.4;padding:40px 15px 40px 15px;transition:all .35s ease}.navbar-custom .navbar-nav>li>a:focus,.navbar-custom .navbar-nav>li>a:hover{background:0 0}@media (max-width:991px){.navbar-custom .navbar-nav{letter-spacing:0;margin-top:1px}.navbar-custom .navbar-nav li{margin:0 20px;padding:0}.navbar-custom .navbar-nav li>a{color:#bbb;padding:12px 0 12px 0}.navbar-custom .navbar-nav>li>a:focus,.navbar-custom .navbar-nav>li>a:hover{background:0 0;color:#fff}.navbar-custom li a{border-bottom:1px solid rgba(73,71,71,.3)!important}.navbar-header{float:none}.navbar-collapse{border-top:1px solid transparent;box-shadow:inset 0 1px 0 rgba(255,255,255,.1)}.navbar-collapse.collapse{display:none!important}.navbar-custom .navbar-nav{background-color:#1a1a1a;float:none!important;margin:0!important}.navbar-custom .navbar-nav>li{float:none}.navbar-header{padding:0 130px}.navbar-collapse{padding-right:0;padding-left:0}}@media (max-width:768px){.navbar-header{padding:0 15px}.navbar-collapse{padding-right:15px;padding-left:15px}}@media (max-width:500px){.navbar-custom .navbar-brand{float:none;display:block;text-align:center;padding:25px 15px 12px 15px}}@media (min-width:992px){.navbar-custom .container-fluid{width:970px;padding-right:15px;padding-left:15px;margin-right:auto;margin-left:auto}}@media (min-width:1200px){.navbar-custom .container-fluid{width:1170px;padding-right:15px;padding-left:15px;margin-right:auto;margin-left:auto}} @font-face{font-family:'Open Sans';font-style:normal;font-weight:300;src:local('Open Sans Light'),local('OpenSans-Light'),url(http://fonts.gstatic.com/s/opensans/v17/mem5YaGs126MiZpBA-UN_r8OXOhs.ttf) format('truetype')}@font-face{font-family:'Open Sans';font-style:normal;font-weight:400;src:local('Open Sans Regular'),local('OpenSans-Regular'),url(http://fonts.gstatic.com/s/opensans/v17/mem8YaGs126MiZpBA-UFW50e.ttf) format('truetype')} @font-face{font-family:Roboto;font-style:normal;font-weight:700;src:local('Roboto Bold'),local('Roboto-Bold'),url(http://fonts.gstatic.com/s/roboto/v20/KFOlCnqEu92Fr1MmWUlfChc9.ttf) format('truetype')}@font-face{font-family:Roboto;font-style:normal;font-weight:900;src:local('Roboto Black'),local('Roboto-Black'),url(http://fonts.gstatic.com/s/roboto/v20/KFOlCnqEu92Fr1MmYUtfChc9.ttf) format('truetype')} </style>
</head>
<body class="">
<nav class="navbar navbar-custom" role="navigation">
<div class="container-fluid padding-0">
<div class="navbar-header">
<a class="navbar-brand" href="#">
{{ keyword }}
</a>
</div>
<div class="collapse navbar-collapse" id="custom-collapse">
<ul class="nav navbar-nav navbar-right" id="menu-menu-principale"><li class="menu-item menu-item-type-post_type menu-item-object-post menu-item-169" id="menu-item-169"><a href="#">About</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-post menu-item-121" id="menu-item-121"><a href="#">Location</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-post menu-item-120" id="menu-item-120"><a href="#">Menu</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-post menu-item-119" id="menu-item-119"><a href="#">FAQ</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-post menu-item-122" id="menu-item-122"><a href="#">Contacts</a></li>
</ul> </div>
</div>
</nav>
<div class="clearfix"></div>
{{ text }}
<br>
{{ links }}
<footer class="site-footer">
<div class="container">
<div class="row">
<div class="col-md-12">
<div class="site-info">
<p>{{ keyword }} 2021</p></div>
</div>
</div>
</div>
</footer>
</body>
</html>";s:4:"text";s:9485:"Considering its high mortality and rapid spread, an effective vaccine is urgently needed to control this pandemic. The country suspended the vaccination program after a report by the U.S. Food and Drug Administration showed rare blood clots in six people who received the vaccine in the United States. Researchers from the "It's not the end-all." The COVID-19 vaccines in use now have been touted for how well they work—the Pfizer vaccine trials found its product to be 95 percent effective in preventing COVID-19 infections after … It showed that 93 per cent of people had produced coronavirus-specific antibodies after receiving the Pfizer vaccine and 87 per cent of people after receiving the AstraZeneca jab. "A vaccine is the first step to helping us return to pre-COVID normality," Goff said. As a result, the academia, industry, and government sectors are … Israel a ... Reinfection is still a real possibility that hasn't been ruled out yet. A small number of infected people in the new study did not have long-lasting immunity after recovery, perhaps because of differences in the amounts of coronavirus they were exposed to. The Hong Kong Hospital Authority observed that two out of three recovering patients had lost 20-30% of lung function – something that can be treated with physiotherapy. In terms of other after-effects, scientists are also currently speculating that coronavirus patients may suffer from reduced lung capacity following a bout of the disease. Covid-19 news: Long covid may improve after vaccine, survey finds. "It's not the end-all." Lee JS, Kim SY, Kim TS, et al. Links with this icon indicate that you are leaving the CDC website.. A longitudinal cohort study in India has found that some people who had COVID-19 lacked meaningful immunity against the novel coronavirus to prevent reinfection months later. The second involves vaccine development. In addition, the hope is that people who've been exposed to COVID-19 also develop an immunity to it. The second involves vaccine development. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a new type of coronavirus that causes the Coronavirus Disease 2019 (COVID-19), which has been the most challenging pandemic in this century. A longitudinal cohort study in India has found that some people who had COVID-19 lacked meaningful immunity against the novel coronavirus to prevent reinfection months later. Here's what you can and can't do after getting the vaccine. According to data published by the CDC Thursday, 66 percent of adults in the United States, age 65 and older, have received at least one shot of the coronavirus vaccine. warnings to governors against easing restrictions yet. The country suspended the vaccination program after a report by the U.S. Food and Drug Administration showed rare blood clots in six people who received the vaccine in the United States. Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Recovery from Mild Coronavirus Disease 2019. What the immune response to the coronavirus says about the prospects for a vaccine Viral immunologists say that results so far have been predictable — … The Merck arrangement, first reported by The Washington Post, comes just days after the Food and Drug Administration granted emergency authorization to the Johnson & Johnson vaccine. As a result, the academia, industry, and government sectors are … Authorities in the Middle Eastern country said they identified more than 60 cases of heart lining and heart muscle inflammation in vaccinated Israelis. Even if you've already had coronavirus and recovered from it, you should get vaccinated against COVID-19 because it is possible to get reinfected, … Oxford challenge trial assessing coronavirus reinfection, immune responses Chief investigator on the study says the results could inform better vaccines and treatments "Because not enough people could sustain an immune response that would protect against reinfection long enough for the virus to extinguish." Findings suggest that the presence of antibodies after the initial infection is not enough to prevent later reinfections. There are … People who have had COVID-19 should still receive the vaccine after they have recovered from their illness, and their isolation period has ended. The governor of Texas says the state can reopen fully next week despite C.D.C. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. Vaccinations are the best option to developing immunity against the new coronavirus.. Israel is now investigating a number of adverse reactions in some of its citizens who got the Pfizer/BioNTech Wuhan coronavirus vaccine. Israel is now investigating a number of adverse reactions in some of its citizens who got the Pfizer/BioNTech Wuhan coronavirus vaccine. Even if you've already had coronavirus and recovered from it, you should get vaccinated against COVID-19 because it is possible to get reinfected, … In addition, the hope is that people who've been exposed to COVID-19 also develop an immunity to it. In an unprecedented effort to curb the pandemic, scientists from around the world have come together to condense a 10-year research and development timeline into roughly 10 months. Merck will help manufacture the Johnson & Johnson vaccine. What the immune response to the coronavirus says about the prospects for a vaccine Viral immunologists say that results so far have been predictable — … "You are still at risk of catching and passing on the coronavirus during this time," it added. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. How long people can fight off reinfection to the new coronavirus and what immune process is involved are key to predicting the dynamics of the pandemic. Intended use of study findings: Findings on the likelihood of reinfection will be used to guide future public health surveillance and prevention guidance for COVID-19. Israel a A better understanding of reinfection and the immune response to SARS-CoV-2 is also needed to inform vaccine planning efforts. Covid-19 news: Long covid may improve after vaccine, survey finds. Authorities in the Middle Eastern country said they identified more than 60 cases of heart lining and heart muscle inflammation in vaccinated Israelis. Selhorst P, Van Ierssel S, Michiels J, et al. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a new type of coronavirus that causes the Coronavirus Disease 2019 (COVID-19), which has been the most challenging pandemic in this century. Oxford challenge trial assessing coronavirus reinfection, immune responses Chief investigator on the study says the results could inform better vaccines and treatments There are … Unless you get extensive testing, you probably won't know for certain whether a recurrence of COVID-19 is a bona fide reinfection or an example of a long-hauler coronavirus infection. Coronavirus vaccine: Lactating mothers now allowed to get COVID-19 vaccine, top FAQs cleared. "A vaccine is the first step to helping us return to pre-COVID normality," Goff said. "Because not enough people could sustain an immune response that would protect against reinfection long enough for the virus to extinguish." A better understanding of reinfection and the immune response to SARS-CoV-2 is also needed to inform vaccine planning efforts. Considering its high mortality and rapid spread, an effective vaccine is urgently needed to control this pandemic. Current evidence suggests that reinfection is uncommon in the 90 days after initial infection. In an unprecedented effort to curb the pandemic, scientists from around the world have come together to condense a 10-year research and development timeline into roughly 10 months. Vaccinations are the best option to developing immunity against the new coronavirus.. It showed that 93 per cent of people had produced coronavirus-specific antibodies after receiving the Pfizer vaccine and 87 per cent of people after receiving the AstraZeneca jab. Young adults who previously contract the Wuhan coronavirus and subsequently recover are not protected against potential reinfection, according to a study. Links with this icon indicate that you are leaving the CDC website.. Intended use of study findings: Findings on the likelihood of reinfection will be used to guide future public health surveillance and prevention guidance for COVID-19. Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. A vaccine is a major component of preventing COVID-19. In fact, it can take at least 14 days for any immunity to start building after the first vaccine dose. According to data published by the CDC Thursday, 66 percent of adults in the United States, age 65 and older, have received at least one shot of the coronavirus vaccine. Brazilian Strain More Likely To Cause Coronavirus Reinfection: Study According to a new study, the Brazilian coronavirus strain is likely to be more transmissible than … Clin Infect Dis 2020. A vaccine is a major component of preventing COVID-19. Here's what you can and can't do after getting the vaccine. ";s:7:"keyword";s:37:"coronavirus reinfection after vaccine";s:5:"links";s:762:"<a href="http://digiprint.coding.al/site/cyykrh/derrick-rose-wife-instagram">Derrick Rose Wife Instagram</a>,
<a href="http://digiprint.coding.al/site/cyykrh/founding-farmers-georgetown">Founding Farmers Georgetown</a>,
<a href="http://digiprint.coding.al/site/cyykrh/bier-garden-encinitas-yelp">Bier Garden Encinitas Yelp</a>,
<a href="http://digiprint.coding.al/site/cyykrh/meriwether-wine-glasses">Meriwether Wine Glasses</a>,
<a href="http://digiprint.coding.al/site/cyykrh/billy-from-school-of-rock-now">Billy From School Of Rock Now</a>,
<a href="http://digiprint.coding.al/site/cyykrh/this-merchant-life-wiki">This Merchant Life Wiki</a>,
<a href="http://digiprint.coding.al/site/cyykrh/epsom-and-ewell-business-grant">Epsom And Ewell Business Grant</a>,
";s:7:"expired";i:-1;}
Mini Shell